Plenary Talk: Valeant’s Approach to Innovation
Valeant Pharmaceuticals is undergoing increased scrutiny. A year ago, J. Michael Pearson, then president and CEO, laid out the company’s vision for developing new tools in ophthalmology.
Presenter:
J. Michael Pearson
Mr. Pearson has been the CEO and serving on the Board since September 2010 and the Chairman of the Board since March 2011.